Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review — Julia Lai‐Kwon (2023) | RDL Network
Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
Mees Egeler, Julia Lai‐Kwon, Renaud Tissier, Itske Fraterman, Anke Kuijpers, Winan J. van Houdt, Sofie Wilgenhof, Aparna D. Rao, Shahneen Sandhu, Rebecca Lee, Hanna Eriksson, Marieke van Leeuwen, Kelly de Ligt, Alexander C.J. van Akkooi, Lonneke V. van de Poll‐Franse
Maarten Egeler, Judith Lijnsvelt, M.W. Lucas, Victoria Atkinson, Muhammad A. Khattak, Miles C. Andrews, M. Boers-Sonderen, Geke A.P. Hospers, M.S. Carlino, Jan Willem de Groot, M. Stevense-den Boer, E. Kapiteijn, K. Suijkerbuijk, P. Rutkowski, A.M. Menzies, Shahneen Sandhu, Astrid A.M. van der Veldt, G.V. Long, C.U. Blank, Lonneke V. van de Poll‐Franse
Discussion(0)
No comments yet. Be the first to comment.